drugset / Trial / NCT00197132

Study In Patients With Insulin Resistance

NCT00197132

Phase 3 Completed 18 enrolled GlaxoSmithKline
RandomizedCrossoverDouble-blindTreatment

Summary

Fluid management study in patients with insulin resistance.

Timeline

Start
2002-10
Primary completion
2003-08
Completion
2003-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosiglitazone Small molecule 4 mg

Indications

No indication recorded.